JP2670680B2
(ja)
*
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
US5129877A
(en)
*
|
1988-04-29 |
1992-07-14 |
University Of Georgia Research Foundation, Inc. |
Receptor-mediated delivery system
|
JP2827287B2
(ja)
*
|
1988-07-05 |
1998-11-25 |
武田薬品工業株式会社 |
水溶性薬物含有徐放型マイクロカプセル
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
US5041292A
(en)
*
|
1988-08-31 |
1991-08-20 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
JPH02212436A
(ja)
*
|
1989-02-14 |
1990-08-23 |
Japan Atom Energy Res Inst |
徐放性基剤
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5538739A
(en)
*
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
EP0423484B1
(de)
*
|
1989-10-16 |
1993-11-03 |
PCD-Polymere Gesellschaft m.b.H. |
Pressling mit retardierter Wirkstofffreisetzung
|
AT397345B
(de)
*
|
1990-04-04 |
1994-03-25 |
Chemiefaser Lenzing Ag |
Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
|
EP0459516A1
(de)
*
|
1990-06-01 |
1991-12-04 |
Kirin-Amgen, Inc. |
Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen
|
JP3249147B2
(ja)
*
|
1990-06-01 |
2002-01-21 |
キリン−アムジエン・インコーポレーテツド |
生理活性蛋白含有経口製剤
|
CA2061703C
(en)
*
|
1992-02-20 |
2002-07-02 |
Rudolf E. Falk |
Formulations containing hyaluronic acid
|
US5824658A
(en)
*
|
1990-09-18 |
1998-10-20 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
US5910489A
(en)
*
|
1990-09-18 |
1999-06-08 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5990096A
(en)
*
|
1990-09-18 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
NO302481B1
(no)
*
|
1990-10-16 |
1998-03-09 |
Takeda Chemical Industries Ltd |
Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
|
IT1247472B
(it)
*
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
WO1994007505A1
(en)
*
|
1991-07-03 |
1994-04-14 |
Norpharmco Inc. |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US5977088A
(en)
*
|
1991-07-03 |
1999-11-02 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US6022866A
(en)
*
|
1991-07-03 |
2000-02-08 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5990095A
(en)
*
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US6218373B1
(en)
|
1992-02-20 |
2001-04-17 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6147059A
(en)
*
|
1992-02-20 |
2000-11-14 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5767106A
(en)
*
|
1992-02-21 |
1998-06-16 |
Hyal Pharmaceutical Corporation |
Treatment of disease and conditions associated with macrophage infiltration
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
EP0595030A3
(de)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Mehrkern-Mikrosphären mit verzögerter Wirkstoffabgabe und Verfahren zu deren Herstellung.
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
JP3390477B2
(ja)
*
|
1993-01-25 |
2003-03-24 |
生化学工業株式会社 |
薬剤組成物及びその製造法
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5478355A
(en)
*
|
1993-03-18 |
1995-12-26 |
United States Surgical Corporation |
Method for improving the in vivo strength retention of a bioabsorbable implantable medical device and resulting medical device
|
HU225496B1
(en)
*
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
IL110787A0
(en)
|
1993-08-27 |
1994-11-11 |
Sandoz Ag |
Biodegradable polymer, its preparation and pharmaceutical composition containing it
|
CA2474701C
(en)
*
|
1993-11-19 |
2009-01-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradeable microparticles containing a biologically active agent
|
AUPM572294A0
(en)
*
|
1994-05-18 |
1994-06-09 |
Vaccine Technologies Pty. Ltd. |
Delivery vehicle for bioactive molecule
|
EP0965336A1
(de)
|
1995-11-09 |
1999-12-22 |
Microbiological Research Authority |
Mikroverkapselte DNA zur Gentherapie
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
KR100236771B1
(ko)
*
|
1997-04-01 |
2000-02-01 |
성재갑 |
히아루론산을 이용한 약물의 서방성 미세입자 제형
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
AU752816B2
(en)
*
|
1997-11-28 |
2002-10-03 |
Curis, Inc. |
An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
FR2778847A1
(fr)
*
|
1998-05-20 |
1999-11-26 |
Jean Pierre Perraud |
Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur
|
US6207718B1
(en)
|
1998-08-07 |
2001-03-27 |
Ontogeny, Inc. |
Pharmaceutical compositions containing hedgehog protein
|
EP1146861B1
(de)
*
|
1999-02-03 |
2005-06-29 |
PowderJect Research Limited |
Hydrogelpartikel formulierungen
|
US6204308B1
(en)
|
1999-03-01 |
2001-03-20 |
Novartis Ag |
Organic compounds
|
EP2305324B1
(de)
*
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medizinische Geräte und Anwendungen aus Polyhydroxyalkanoat-Polymeren
|
US7582311B1
(en)
*
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7651703B2
(en)
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US8435939B2
(en)
|
2000-09-05 |
2013-05-07 |
Biokine Therapeutics Ltd. |
Polypeptide anti-HIV agent containing the same
|
KR20040007596A
(ko)
|
2001-05-23 |
2004-01-24 |
다나베 세이야꾸 가부시키가이샤 |
골절 치료 촉진용 조성물
|
US20040180900A1
(en)
|
2001-05-23 |
2004-09-16 |
Masaharu Takigawa |
Therapeutic composition for repairing chondropathy
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
US20050191361A1
(en)
*
|
2001-08-03 |
2005-09-01 |
Powederject Research Ltd. |
Hydrogel particle formation
|
CA2537158C
(en)
|
2002-08-27 |
2014-07-22 |
Hirokazu Tamamura |
Cxcr4 antagonist and use thereof
|
US20040226620A1
(en)
|
2002-09-26 |
2004-11-18 |
Daniel Therriault |
Microcapillary networks
|
JPWO2004037272A1
(ja)
*
|
2002-10-22 |
2006-02-23 |
独立行政法人科学技術振興機構 |
デング熱ウィルス感染阻害剤
|
US7053125B2
(en)
|
2002-11-14 |
2006-05-30 |
The Board Of Trustees Of The University Of Illinois |
Controlled dispersion of colloidal suspension by comb polymers
|
WO2004101002A2
(en)
|
2003-05-08 |
2004-11-25 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
US7141617B2
(en)
|
2003-06-17 |
2006-11-28 |
The Board Of Trustees Of The University Of Illinois |
Directed assembly of three-dimensional structures with micron-scale features
|
EP1651273B1
(de)
*
|
2003-07-08 |
2012-08-29 |
Tepha, Inc. |
Poly-4-hydroxybutyrat-matrizes zur kontinuierlichen arzneistoffzuführung
|
JP2007503221A
(ja)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート神経再生デバイス
|
US7867511B2
(en)
|
2004-01-23 |
2011-01-11 |
Travanti Pharma Inc. |
Abuse potential reduction in abusable substance dosage form
|
FI116625B
(fi)
|
2004-01-28 |
2006-01-13 |
Macrocrystal Oy |
Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
|
US20050271726A1
(en)
*
|
2004-06-02 |
2005-12-08 |
Albert Crum |
Immune enhancing compositions and methods of use thereof
|
EP1778305B1
(de)
*
|
2004-08-03 |
2010-07-07 |
Tepha, Inc. |
Nichtkräuselnde polyhydroxyalkanoatnähte
|
CA2596283C
(en)
*
|
2005-01-28 |
2011-11-01 |
Tepha, Inc. |
Embolization using poly-4-hydroxybutyrate particles
|
DE102006013531A1
(de)
*
|
2006-03-24 |
2007-09-27 |
Lts Lohmann Therapie-Systeme Ag |
Polylactid-Nanopartikel
|
CN101522164B
(zh)
*
|
2006-09-13 |
2014-03-26 |
提升肤质产品公司 |
用于治疗皮肤的化妆品组合物及其方法
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
WO2008075369A2
(en)
|
2006-12-21 |
2008-06-26 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
|
US7956102B2
(en)
|
2007-04-09 |
2011-06-07 |
The Board Of Trustees Of The University Of Illinois |
Sol-gel inks
|
US7922939B2
(en)
|
2008-10-03 |
2011-04-12 |
The Board Of Trustees Of The University Of Illinois |
Metal nanoparticle inks
|
US8187500B2
(en)
|
2008-10-17 |
2012-05-29 |
The Board Of Trustees Of The University Of Illinois |
Biphasic inks
|
US9155780B2
(en)
|
2009-02-11 |
2015-10-13 |
Yeda Research And Development Co. Ltd. |
Short beta-defensin-derived peptides
|
KR101719339B1
(ko)
|
2009-06-14 |
2017-03-23 |
바이오카인 테라퓨틱스 리미티드 |
혈소판 수준을 증가시키는 펩타이드 요법
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
US10500303B2
(en)
|
2014-08-15 |
2019-12-10 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
CA2969429C
(en)
|
2014-12-11 |
2020-10-27 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
CN111375066B
(zh)
|
2015-07-16 |
2023-04-25 |
百欧肯治疗有限公司 |
治疗癌症的组合物及方法
|
ES2830726T3
(es)
|
2016-02-23 |
2021-06-04 |
Biolinerx Ltd |
Método para seleccionar un régimen de tratamiento para la leucemia mieloide aguda (LMA)
|
WO2018138267A1
(en)
|
2017-01-27 |
2018-08-02 |
Cinfa Biotech S.L. |
Method for determining the efficacy of a g-csf containing composition
|
US11389844B2
(en)
|
2018-03-20 |
2022-07-19 |
Verde Environmental Technologies, Inc. |
Blister pack disposal system
|
CN115970051B
(zh)
*
|
2023-02-09 |
2023-08-29 |
辽宁天贺生物科技研究院有限公司 |
可降解组织工程填充材料及其制备方法和用途
|